Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis

[1]  N. Galal,et al.  Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis , 2016, Electronic physician.

[2]  M. Epstein,et al.  Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children , 2016, The Journal of Rheumatology.

[3]  M. Boers,et al.  A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia , 2016, Arthritis Research & Therapy.

[4]  A. Marotta,et al.  Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis , 2016, Arthritis Research & Therapy.

[5]  A. Marotta,et al.  Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab , 2015, Arthritis Research & Therapy.

[6]  A. Marotta,et al.  14-3-3η in “Seronegative” Rheumatoid Arthritis , 2015, The Journal of Rheumatology.

[7]  K. Siminovitch,et al.  14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis , 2015, The Journal of Rheumatology.

[8]  A. Marotta,et al.  AB1029 Serum 14-3-3ETA is Present in JIA and is not Associated with RF+ Polyarthritis , 2015 .

[9]  J. Verbsky,et al.  Polyarticular juvenile idiopathic arthritis – epidemiology and management approaches , 2014, Clinical epidemiology.

[10]  A. Marotta,et al.  14-3-3η: a novel biomarker platform for rheumatoid arthritis. , 2014, Clinical and experimental rheumatology.

[11]  K. Siminovitch,et al.  Serum 14-3-3η is a Novel Marker that Complements Current Serological Measurements to Enhance Detection of Patients with Rheumatoid Arthritis , 2014, The Journal of Rheumatology.

[12]  C. Allaart,et al.  14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage , 2014, Arthritis Research & Therapy.

[13]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[14]  A. Chauhan,et al.  Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis , 2013, Pediatric Rheumatology.

[15]  I. Petersson,et al.  Disease Course, Outcome, and Predictors of Outcome in a Population-based Juvenile Chronic Arthritis Cohort Followed for 17 Years , 2013, The Journal of Rheumatology.

[16]  H. Hussein,et al.  Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial). , 2013, Joint, bone, spine : revue du rhumatisme.

[17]  S. Prahalad,et al.  Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis , 2012, Pediatric Rheumatology.

[18]  Alberto Martini,et al.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features , 2011, Arthritis care & research.

[19]  R. Lodha,et al.  Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis , 2010, Indian journal of pediatrics.

[20]  T. Koepsell,et al.  Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. , 2009, Rheumatology.

[21]  Alberto Martini,et al.  Development and validation of a composite disease activity score for juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.

[22]  A. Šimundić,et al.  Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis , 2009, Clinical chemistry and laboratory medicine.

[23]  I. Lacreuse,et al.  Conflict of Interest: None , 2009 .

[24]  H. Youssef,et al.  Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Juvenile Idiopathic Arthritis , 2008, Immunological investigations.

[25]  A. Chauhan,et al.  Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.

[26]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[27]  J. Fries,et al.  Measurement of health status in children with juvenile rheumatoid arthritis. , 1994, Arthritis and rheumatism.